Mark John Neavyn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark John Neavyn has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Kavita M. Babu
Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA, USA
2 shared publications Steven B. Bird
University of Massachusetts Medical School
2 shared publicationsEdward W. Boyer
University of Massachusetts Medical School
1 shared publicationEike Blohm
University of Massachusetts Medical School
1 shared publication
Latest Publications
- 20 March 2014
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 10 (3) , 269-279
Medical Marijuana and Driving: a Review
Medical marijuana remains a highly debated treatment regimen despite removal of state penalties against care providers prescribing the drug and patients treated with the drug in many areas of the USA. The utility of marijuana in specific medical conditions has been studied at length, but its effects on driving performance and risk of motor vehicle collision remain unclear. As with other medications that affect psychomotor function, the healthcare provider should be informed of the potential risks of driver safety prior to prescribing this psychotropic drug to give appropriate anticipatory guidance for appropriate use. The goal of this narrative review is to assess the current literature regarding marijuana as it relates to driving performance and traffic safety. With a foundation in the pharmacology of cannabinoids, we consider the limitations of testing cannabinoid and metabolite concentration. In addition, we will review studies on driving performance and epidemiological studies implicating marijuana in motor vehicle collisions. The increasing prevalence of medical marijuana laws in the USA suggests that clinicians should be aware of marijuana’s influence on public safety. Patients should abstain from driving for 8 h if they achieve a subjective “high” from self-treatment with smoked marijuana and should be aware of the cumulative effects of alcohol and other psychoactive xenobiotics.
- 20 March 2014
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 10 (3) , 269-279
Medical Marijuana and Driving: a Review
Medical marijuana remains a highly debated treatment regimen despite removal of state penalties against care providers prescribing the drug and patients treated with the drug in many areas of the USA. The utility of marijuana in specific medical conditions has been studied at length, but its effects on driving performance and risk of motor vehicle collision remain unclear. As with other medications that affect psychomotor function, the healthcare provider should be informed of the potential risks of driver safety prior to prescribing this psychotropic drug to give appropriate anticipatory guidance for appropriate use. The goal of this narrative review is to assess the current literature regarding marijuana as it relates to driving performance and traffic safety. With a foundation in the pharmacology of cannabinoids, we consider the limitations of testing cannabinoid and metabolite concentration. In addition, we will review studies on driving performance and epidemiological studies implicating marijuana in motor vehicle collisions. The increasing prevalence of medical marijuana laws in the USA suggests that clinicians should be aware of marijuana’s influence on public safety. Patients should abstain from driving for 8 h if they achieve a subjective “high” from self-treatment with smoked marijuana and should be aware of the cumulative effects of alcohol and other psychoactive xenobiotics.
- 4 October 2013
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 10 (1) , 3-6
Suicide and the Surrogate
- 4 October 2013
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 10 (1) , 3-6
Suicide and the Surrogate
- 30 April 2013
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 9 (3) , 250-254
Sodium Acetate as a Replacement for Sodium Bicarbonate in Medical Toxicology: a Review
Sodium bicarbonate is central to the treatment of many poisonings. When it was placed on the FDA drug shortage list in 2012, alternative treatment strategies to specific poisonings were considered. Many hospital pharmacies, poison centers, and medical toxicologists proposed sodium acetate as an adequate alternative, despite a paucity of data to support its use in medical toxicology. The intention of this review is to educate the clinician on the use of sodium acetate and to advise them on the potential adverse events when given in excess. We conducted a literature search focused on the pharmacology of sodium acetate, its use as a buffer in pathologic acidemia and dialysis baths, and potential adverse events associated with excess sodium acetate infusion. It appears safe to replace sodium bicarbonate infusion with sodium acetate on an equimolar basis. The metabolism of acetate, however, is more complex than bicarbonate. Future prospective studies will be needed to confirm the efficacy of sodium acetate in the treatment of the poisoned patient.
- 30 April 2013
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 9 (3) , 250-254
Sodium Acetate as a Replacement for Sodium Bicarbonate in Medical Toxicology: a Review
Sodium bicarbonate is central to the treatment of many poisonings. When it was placed on the FDA drug shortage list in 2012, alternative treatment strategies to specific poisonings were considered. Many hospital pharmacies, poison centers, and medical toxicologists proposed sodium acetate as an adequate alternative, despite a paucity of data to support its use in medical toxicology. The intention of this review is to educate the clinician on the use of sodium acetate and to advise them on the potential adverse events when given in excess. We conducted a literature search focused on the pharmacology of sodium acetate, its use as a buffer in pathologic acidemia and dialysis baths, and potential adverse events associated with excess sodium acetate infusion. It appears safe to replace sodium bicarbonate infusion with sodium acetate on an equimolar basis. The metabolism of acetate, however, is more complex than bicarbonate. Future prospective studies will be needed to confirm the efficacy of sodium acetate in the treatment of the poisoned patient.